Results 231 to 240 of about 6,274,440 (386)
Targeting S-Nitrosylation to Overcome Therapeutic Resistance in NRAS-Driven Melanoma. [PDF]
Srivastava J, Premi S.
europepmc +1 more source
THE MECHANISM OF THE INHIBITION BY CARBONIC ACID OF THE SMOOTH MUSCLE CONTRACTION PRODUCED BY HISTAMINE AND OXYTOCIN [PDF]
B Halpern+3 more
openalex +1 more source
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma+9 more
wiley +1 more source
TAK1 inhibition activates pore-forming proteins to block intracellular bacterial growth through modulating mitochondria. [PDF]
López-Pérez W+9 more
europepmc +1 more source
Kinetics of the Thermal Decomposition of Dimethylmercury. I. Cyclopentane Inhibition [PDF]
M. E. Russell, Richard B. Bernstein
openalex +1 more source
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu+12 more
wiley +1 more source
Hierarchical Organization of Bilateral Prefrontal-Basal Ganglia Circuits for Response Inhibition Control. [PDF]
Lin L+7 more
europepmc +1 more source
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci+6 more
wiley +1 more source